29.01.2015 Views

Conference PPT (5 MB) - Institute for Oral Health

Conference PPT (5 MB) - Institute for Oral Health

Conference PPT (5 MB) - Institute for Oral Health

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Oral</strong> <strong>Health</strong> in Aging America:<br />

<strong>Oral</strong> –Systemic <strong>Health</strong> Linkages<br />

Linda C. Niessen, DMD<br />

LCN


Acknowledgements<br />

• Baylor College of Dentistry, Texas A&M HSC<br />

• DENTSPLY International


VA North Texas <strong>Health</strong> Care System


Purpose<br />

• Examine the oral health-<br />

systemic health link and the<br />

role that oral inflammation<br />

can play on systemic<br />

diseases<br />

• Discuss the most common<br />

medical conditions and<br />

medications and their<br />

effects on oral health care<br />

• Identify future oral health<br />

system needs to insure oral<br />

health in an aging America


Thesis<br />

• The mouth is connected to the<br />

rest of the body.<br />

– New research is identifying the<br />

effects of oral infection and<br />

inflammation on target organs.<br />

• Caring <strong>for</strong> older adults makes<br />

these linkages readily<br />

apparent.<br />

– Dental professionals need<br />

greater interaction with the<br />

overall health care system.<br />

• Patients are beginning to<br />

understand the relationship<br />

between oral health and<br />

systemic health.


Thesis<br />

• <strong>Oral</strong>–systemic link will re-assert<br />

the importance and value of<br />

prevention of oral diseases.<br />

– <strong>Oral</strong> diseases play a pivotal role in chronic<br />

disease management<br />

• Patients value preventive care,<br />

even when they don’t t comply.<br />

• Preventive care tells patients<br />

you value their future,<br />

regardless of how long it is!


Changing Demographics and<br />

Expectations<br />

• This is not your mother’s<br />

aging society<br />

• Baby boomers will redefine<br />

what it means to age<br />

successfully, gracefully!<br />

• It includes maintaining<br />

good health and good oral<br />

health<br />

• Older adults will seek<br />

in<strong>for</strong>mation about their<br />

health from a variety of<br />

sources


Life Expectancy of Women and Men, US<br />

20<br />

15<br />

10<br />

5<br />

0<br />

65<br />

years<br />

75<br />

years<br />

85<br />

years<br />

95<br />

years<br />

100<br />

years<br />

Men-Black 14.5 9.4 5.7 3.6 2.9<br />

Men-White 16.3 10.1 5.6 3.1 2.4<br />

Women-Black 17.4 11.2 6.5 3.6 2.7<br />

Women-White 19.2 12.1 6.7 3.5 2.7<br />

Source: Centers <strong>for</strong> Disease Control and Prevention, US National Center <strong>for</strong> <strong>Health</strong><br />

Statistics, Life Expectancy by Age, Race and Sex in the United States, 2000.


Successful Aging<br />

• Engages with life<br />

• Avoids disease<br />

• Maintains high<br />

cognitive and<br />

physical function


Successful Aging<br />

100%<br />

80%<br />

70%<br />

60%<br />

40%<br />

30%<br />

20%<br />

0%<br />

Factors<br />

Lifestyle<br />

Genetics


Genes are not your destiny


Principles of Geriatric Medicine<br />

• Age Related Changes<br />

• Disease Related Changes<br />

• Atypical Presentation of Disease<br />

• Multiple Pathology<br />

• Under Reporting of Disease Symptoms<br />

• Functional Status Assessment<br />

• Role of Interdisciplinary Team


Multiple Pathology<br />

• Heart disease<br />

• Hypertension<br />

• Arthritis<br />

• Stroke<br />

• Diabetes<br />

• Depression…<br />

– be<strong>for</strong>e you even<br />

look in the mouth<br />

Your initial medical history and medication history will<br />

take longer!


Chronic Diseases in Older Adults<br />

• Top 5 Causes of Death<br />

– Heart Disease<br />

– Cancer<br />

– Stroke<br />

– Alzheimer’s s disease<br />

– Respiratory disease<br />

• Top 5 Chronic Diseases<br />

– Arthritis<br />

– Hypertension<br />

– Heart Disease<br />

– Hearing Impairments<br />

– Cataracts<br />

What we die from!<br />

What we live with!


Heterogeneity of Elders<br />

• Active Elders 85%<br />

• Chronically Ill 10%<br />

• Nursing Home 5%<br />

Residents<br />

The differences in status often result from the number of chronic<br />

diseases and ability to maintain function, e.g. activities of daily<br />

living.


Cardiovascular Disease in the Elderly<br />

• Hypertension<br />

• Myocardial Infarct<br />

• Congestive Heart Failure<br />

• Atrial Fibrillation<br />

• Conduction System<br />

Defects<br />

• Valvular Heart Disease<br />

Does your health history <strong>for</strong>m capture these different <strong>for</strong>ms of<br />

heart disease and the medications taken to manage them


Cardiac Disease and Treatment<br />

• Organ damage due to<br />

hypertension<br />

• Muscle damage due to<br />

decreased blood supply<br />

(angina, MI)<br />

• Conduction system<br />

defect (arrythmias)<br />

• Pump malfunction (CHF)<br />

• Atrial fibrillation<br />

• Valvular disease<br />

• Diuretics, ACEI, CCB,<br />

β-blockers<br />

• NTG, CABG<br />

• Pacemaker, implanted<br />

defibrillation<br />

• Digoxin<br />

• Plavix (clopigrel), ASA<br />

• Prosthetic Valves


<strong>Oral</strong> Examination<br />

• Caries<br />

• Periodontal disease<br />

• <strong>Oral</strong> soft tissue<br />

lesion<br />

• Missing teeth


Cardiovascular Disease and Periodontal<br />

Infections<br />

• Evidence continues to mount that periodontal<br />

infections play a contributory role in the development<br />

of cardiovascular disease (remember Dr. Roizen’s<br />

video yesterday)<br />

• Are we ready to recommend and reimburse<br />

periodontal treatment in the patient with moderate-<br />

severe, localized or generalized periodontal disease<br />

as part of the management of his/her cardiovascular<br />

disease<br />

Source: R Demmer and M. Desvarieux. Periodontal<br />

infections and cardiovascular disease. JADA 137: 14s-<br />

20s, October, 2006.


Dental Implications of<br />

Cardiovascular Treatment<br />

• Physician consult<br />

– When in doubt, ask<br />

• Hypertension<br />

– Check BP at each dental visit<br />

• Medications<br />

– Xerostomia –BB, ACEI, CCB, ARB<br />

– Gingival Overgrowth-nifedipine<br />

– Lichenoid reactions<br />

– Bleeding – Plavix, Aspirin<br />

• Valvular Disease<br />

– New SBE Guidelines


CARDIAC CONDITIONS FOR WHICH PROPHYLAXIS FOR<br />

DENTAL PROCEDURES IS RECOMMENDEDFOR<br />

PREVENTION OF BACTERIAL ENDOCARDITIS*<br />

• Prosthetic cardiac valve<br />

• Previous infective endocarditis<br />

• Congenital Heart Disease (CHD)<br />

– Unrepaired cyanotic CHD, including palliative shunts and conduits<br />

– Completely repaired congenital heart defect with prosthetic material or device,<br />

whether placed by surgery or by catheter intervention, during the e first 6<br />

months after the procedure (endothelialization occurs within 6 month m<br />

of<br />

procedure)<br />

– Repaired CHD with residual defects at the site or adjacent to the e site of a<br />

prosthetic patch or prosthetic device (which inhibits endothelialization)<br />

lization)<br />

• Cardiac transplant recipients who develop cardiac valvulopathy<br />

*Except <strong>for</strong> the cardiac conditions listed above, antibiotic prophylaxis is no longer<br />

recommended <strong>for</strong> any cardiac condition or problem.<br />

Source: Current American Heart Association Guidelines<br />

Published May 8, 2007, Circulation, , Vol. 115.


Dental Procedures and<br />

Rational <strong>for</strong> Revisions<br />

• All dental procedures that involve manipulation of gingival<br />

tissue or the periapical region of the teeth or per<strong>for</strong>ation of<br />

the oral mucosa (not needed <strong>for</strong> LA through non-infected<br />

tissue, radiographs, placement of and/or adjustment of<br />

removable or orthodontic appliances, shedding of 1 o teeth)<br />

• Infective endocarditis (IE) more likely to result from frequent<br />

exposure to random bacteremias associated with daily<br />

activities<br />

• Maintenance of optimal oral health & hygiene may reduce<br />

incidence of bacteremia from daily activities and may be<br />

more important than prophylactic antibiotics <strong>for</strong> a dental<br />

procedure to reduce the risk of IE<br />

Source: Wilson, et al. Prevention of infective endocarditis: Guidelines from<br />

the American Heart Association. JADA 138:739-760, 760, June 2007.


Cerebrovascular Accident<br />

• 500,000 new cases each<br />

year<br />

• 3rd most common cause<br />

of death<br />

• Can be thrombolytic or<br />

hemorrhagic<br />

• Most common sequelae-<br />

motor loss of dominant<br />

side


Cerebrovascular Accident<br />

• Study reported a 400%<br />

increase in stroke risk<br />

associated with<br />

periodontitis but found<br />

no relationship between<br />

caries and stroke.<br />

• <strong>Oral</strong> inflammation plays<br />

a role in the mechanism<br />

of action<br />

Source: Grau AJ, Becher H, Ziegler CM et al. Periodontal disease<br />

as a risk factor <strong>for</strong> ischemic stroke. Stroke 35(2): 496-501, 2004.


Dental Implications of CVA<br />

• Transportation to office<br />

• Dominant hand function and<br />

oral self care abilities<br />

• Aphasia<br />

• Depression<br />

• Transfer to dental chair<br />

• Loss of oral motor function<br />

• Post-op op meds:<br />

– Anti-coagulants<br />

– Bleeding-need need INR data<br />

– Gingival overgrowth


•Dilantin (Anticonvulsant)<br />

•Nifedipine (Calcium<br />

Channel Blocker)<br />

•Cyclosporine<br />

(Immunosuppressive)<br />

•New BP medications<br />

• Isn’t dental care<br />

medically necessary<br />

after a CVA as part of<br />

the management


Diabetes Mellitus<br />

• >9% of population<br />

• Onset<br />

– Type I-5-10% I<br />

(Juvenile)<br />

– Type II- 90-95% 95% (Adult)<br />

• Medications<br />

– <strong>Oral</strong> hypoglycemic<br />

– Insulin<br />

• Research on diabetes<br />

and perio disease most<br />

developed


Dental Implications<br />

• Higher risk of infections<br />

– periodontal disease<br />

– oral candida<br />

• Research is showing that when<br />

diabetics have their periodontal<br />

infections treated, their insulin<br />

requirements decrease<br />

• Doesn’t t this suggest that<br />

treatment of periodontal<br />

infections is part of the<br />

management of the diabetic<br />

patient


Source: Considerations <strong>for</strong> treating the dental patient with diabetes.<br />

American Dental Association, 2003.<br />

Considerations <strong>for</strong> Dental Treatment<br />

• More frequent recall<br />

• Emphasis on soft<br />

tissue management<br />

– SRP prn<br />

– Antiobiotic treatment<br />

• AM appointments (or<br />

when insulin at peak)


Diabetes – The poster disease <strong>for</strong><br />

reconnecting reimbursement <strong>for</strong><br />

oral care with medical care<br />

• In the management of the<br />

diabetic patient, why can<br />

the diabetic patient have<br />

his:<br />

– blood glucose managed<br />

– cardiovascular disease<br />

treated<br />

– eye disease resolved<br />

– foot care evaluated<br />

– periodontal infections<br />

ignored


Osteoporosis<br />

• Loss of bone mass and<br />

architecture<br />

• Increased risk of<br />

fracture<br />

• Female to male ratio<br />

4:1<br />

• 1.5 million fractures<br />

annually


Treatment of Osteoporosis<br />

• Vitamin D<br />

• Calcium<br />

• Weight bearing<br />

exercise (not<br />

swimming)<br />

• Strength training<br />

• Fluoride (Pak et al)<br />

• Bisphosphonates<br />

– Fosamax, Aredia,<br />

Boniva


Bisphosphonate Induced<br />

Osteonecrosis of the Jaw (ONJ)<br />

Slide courtesy of Dr. Harry<br />

Gilbert, VAMC Houston<br />

Zolendronic acid (Zometa) - IV<br />

Novartis<br />

Pamidronate (Aredia) - IV<br />

Novartis<br />

Alendronate (Fosamax) - oral<br />

Merck<br />

Risendronate (Actonel) - oral<br />

Procter and Gamble<br />

Pharmaceuticals


Risk of Osteonecrosis of the Jaw <strong>for</strong><br />

Patients Taking Bisphosphonates<br />

• Risk <strong>for</strong> developing ONJ with IV bisphosphonates<br />

is ~10-12% 12% (multiple myeloma, breast CA-any CA<br />

metastatic to bone; drugs control osteoclasts).<br />

• Risk <strong>for</strong> developing ONJ with oral bisphosphonates<br />

is less than 1%.<br />

• Lower risk <strong>for</strong> ONJ in first 6 months of IV therapy;<br />

first 3 years of oral treatment.<br />

Source: Migliorati, CA, JA Casiglis, J. Epstein, PI Jacobsen, MA Siegel, SB Woo.<br />

Managing the care of patents with bisphospnhonate-associated associated osteonecrosis:<br />

An American Academy of <strong>Oral</strong> Medicine position paper. JADA 136(12):1658<br />

):1658-68, 68,<br />

2005.


Strategies <strong>for</strong> Patients on<br />

• Take a good history<br />

Bisphosphonates<br />

– <strong>Oral</strong> bisphosphonates < IV<br />

Bisphosphonates<br />

– <strong>Oral</strong> bisphosphonates < 3 yrs<br />

• Consult with patient’s s MD<br />

• Treatment Planning<br />

– In<strong>for</strong>med consent<br />

– Tooth conserving procedures<br />

(endo v. extraction)<br />

• Prevention<br />

– Good oral hygiene<br />

– Regular dental visits<br />

Slide courtesy of Dr. Richard<br />

Davis, Cleveland, VAMC<br />

Source: Robert Marx, Bisphosphonate-induced Osteonecrosis of the Jaw, 2006.


Rheumatoid Arthritis and<br />

Osteoarthritis<br />

• Inflammatory<br />

mechanism<br />

• Disabilities<br />

– How does patient get<br />

to your office<br />

– Evaluate oral hygiene<br />

self care<br />

• Medications<br />

– Pain meds


Professional <strong>Oral</strong> Care<br />

• Control biofilms with<br />

scaling and root planing<br />

based on patient’s s needs -<br />

PRN<br />

• Rein<strong>for</strong>ce daily oral self<br />

care<br />

• Will require more of the<br />

dental hygienist’s s time<br />

• Consider reimbursing <strong>for</strong><br />

time rather than CPT code<br />

– Or add co-morbities


Degenerative Joint Disease<br />

• Can lead to joint<br />

replacement<br />

• Can have total joint<br />

replaced or pins placed<br />

to repair fractures<br />

• Joint replacements<br />

require antibiotics <strong>for</strong><br />

high risk patients


ADA Guidelines on<br />

Prophylactic Antibiotics <strong>for</strong><br />

Patients With Prosthetic Joints<br />

If:<br />

<strong>Health</strong>y<br />

Risk Factors<br />

NO<br />

YES<br />

Source: Antibiotic prophylaxis <strong>for</strong> dental patients with total<br />

joint replacements. JADA, 134:895-898 July 2003.


Patients at potential increased risk<br />

of hematogenous total joint<br />

• All patients during first two years<br />

following joint replacement<br />

• Immunocompromised/immuno-<br />

suppressed patients<br />

– Inflammatory arthropathies: rheumatoid arthritis,<br />

systemic lupus erythematosus<br />

– Drug- or radiation-induced induced immunosuppression<br />

• Patients with co-morbidities


Patients at potential increased risk<br />

of hematogenous total joint<br />

• Patients with co-morbidities<br />

– Previous prosthetic joint infections<br />

– Malnourishment<br />

– Hemophilia<br />

– HIV Infection<br />

– Insulin-dependent (Type 1) diabetes<br />

– First 2 years following joint placement<br />

– Malignancy<br />

Source: Antibiotic prophylaxis <strong>for</strong> dental patients with total<br />

joint replacements. JADA, 134:895-898 July 2003.


Medication Use<br />

• OTC Medications<br />

(not perceived as<br />

medicines or<br />

serious)<br />

• Multiple<br />

prescription<br />

medications<br />

• Compliance<br />

• Interactions<br />

• Change frequently


Medications<br />

• Prescription Meds<br />

– Anti-hypertensives<br />

– Diabetic meds<br />

– Cholesterol<br />

lowering<br />

– Cardiac meds<br />

– NSAID (anti-<br />

arthritics)<br />

– Anti-depressants<br />

• OTC Meds<br />

– Antacids (sugar<br />

content)<br />

– Analgesics (ASA)<br />

– Vitamins (E and C)<br />

– Herbal<br />

Supplements<br />

» Glucosamine<br />

» Chondroitin sulfate<br />

» Co-enzyme Q<br />

Bleeding and oral dryness among concerns with multiple<br />

medication use.


Saliva: A Natural Resource


Signs of Xerostomia<br />

• Increased caries,<br />

especially root caries<br />

• Epithelial atrophy<br />

• Inflammatory fissuring<br />

• <strong>Oral</strong> candida infection


Differential Diagnosis of<br />

Alterations in Salivary Flow<br />

• Multiple medications<br />

• Head and neck<br />

radiation<br />

• Endocrine changes<br />

• Primary salivary gland<br />

pathology


Medications Causing <strong>Oral</strong> Dryness<br />

• Antidepressants<br />

• Antihistamines<br />

• Antihypertensives<br />

• Antineoplastics<br />

• Antipsychotics<br />

• Antispasmodics<br />

• Decongestants<br />

• Diuretics<br />

• Tranquilizers<br />

Medications taken on a regular basis <strong>for</strong> a<br />

long time cause more oral dryness.


Treatment Options<br />

• Hydration<br />

– Older adults often<br />

don’t t thirst<br />

– Frequent liquids<br />

– Reduce liquids<br />

containing caffeine or<br />

alcohol<br />

• Mechanical<br />

– Chewing xylitol gum


Johnson JT,et al. <strong>Oral</strong> pilocarpine in post-irradiation xerostomia in patients<br />

with head and neck cancer. New Engl J Med, 329:390, 1993<br />

Prescription Medications<br />

• Pilocarpine<br />

(Salagen®)<br />

– 5 mg. tid (not to<br />

exceed 30 mg/day)<br />

– Treat <strong>for</strong> minimum<br />

of 90 days<br />

– Contraindications:<br />

Asthma, glaucoma<br />

– Side effects:<br />

sweating<br />

• Cevimeline<br />

(Evoxac)<br />

– 30-60 mg. Tid (not<br />

to exceed 180<br />

mg/day)<br />

– Contraindications:<br />

asthma, glaucoma,<br />

severe COPD<br />

– Side effects:<br />

sweating


Salivary Substitutes<br />

• Provide palliative<br />

relief from oral<br />

dryness<br />

• Replace minerals<br />

and enzymes in<br />

saliva<br />

• Can use prn<br />

• Contraindicated-<br />

alcohol-based<br />

mouthrinses<br />

• Ingredients include:<br />

– ions: Na, Cl, Mg, F, Ca,<br />

Phosphates<br />

– flavoring: lemon, mint,<br />

neutral<br />

– lubricants/sweeteners-<br />

glycerin, sorbitol,<br />

xylitol<br />

– preservative-paraben<br />

paraben<br />

– enzymes- lactoferrins,<br />

peroxidases, etc


Risk Assessment<br />

Who is susceptible<br />

LCN


Risk Assessment<br />

There are no generic<br />

patients.


Risk Assessment<br />

<strong>Oral</strong>-systemic health<br />

research is<br />

demonstrating the<br />

importance of oral<br />

inflammation and<br />

that oral care is<br />

critical to the<br />

management of<br />

chronic diseases.


Maintaining teeth is<br />

sometimes just as<br />

difficult- but plays a<br />

key role in daily<br />

eating, speaking,<br />

smiling, swallowing.<br />

Losing teeth is<br />

psychological and<br />

physically difficult.


Conclusions<br />

• Mouth is connected to the rest<br />

of the body.<br />

• Older adults demonstrate the<br />

connection between systemic<br />

diseases and medications on<br />

oral health more readily than<br />

other populations<br />

• Presence of oral infection &<br />

inflammation can exacerbate<br />

systemic illnesses and vice<br />

versa<br />

• We need a social marketing<br />

campaign about the<br />

relationship b/w oral disease &<br />

systemic diseases


Conclusions<br />

• <strong>Oral</strong> diseases can play a<br />

pivotal role in chronic disease<br />

management.<br />

• High level of interaction<br />

between the dental care<br />

system and the medical care<br />

system is critical to healthy<br />

aging.<br />

• Linking financing &<br />

reimbursement between oral<br />

care system & medical system<br />

may improve system<br />

efficiencies and lower costs<br />

• Very vulnerable continue to<br />

have the least access to oral<br />

health care


What would you do differently<br />

as a result of this conference<br />

• Will it be to control your own aging through gene expression<br />

and reduce your stress per Dr. Roizen and Dr. Singer<br />

• Become an advocate and care <strong>for</strong> more older adults per Dr.<br />

Shuman<br />

• Examine new methods of financing & reimbursement per Dr.<br />

Jones<br />

• Educate next generation of dental and medical professionals<br />

together per Dr. Berkey<br />

• Develop novel community delivery programs per Dr.<br />

Helgeson<br />

• Let your voice be heard and insure that oral health is included<br />

in the debate on universal health coverage in the US per Dr.<br />

Olsen


“May you die very young,<br />

at a very old age.”

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!